Randomized Clinical Trial for Treatment of Meibomian Gland Dysfunction and Evaporative Dry Eye
Interventional
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment
Meibomian Gland Assessment (Total Meibomian Gland Secretion Score)
Evaluation of secretion characteristics from the gland orifices along the lower eyelid. Assessment was based on the grading scale: 3 (clear liquid secretion), 2 (cloudy liquid secretion), 1 (inspissated), 0 (no secretion). The total meibomian gland secretion score was the sum of the grades for all 15 glands with a range of 0 to 45.
Baseline, 2 Weeks and 4 Weeks
No
Christy Stevens, OD
Study Director
TearScience, Inc.
United States: Institutional Review Board
LF001
NCT00832130
February 2009
August 2009
Name | Location |
---|---|
Hinsdale, Illinois 60521 | |
Alexandria, Minnesota 56308 | |
Albany, Georgia 31701 | |
Philadelphia, Pennsylvania 19104 | |
Flint, Michigan 48532 | |
Louisville, Kentucky 40207 | |
Little Rock, Arkansas 72205-7199 | |
Boston, Massachusetts | |
Charlotte, North Carolina |